Novocure develops and commercializes Tumor Treating Fields (TTFields), a proprietary therapy designed to disrupt cancer cell division. The company operates at the crossroad of advanced medical technology and cutting-edge biotechnology, pioneering oncology innovation for the treatment of aggressive cancers.
